Literature DB >> 29311060

Transposition of Tn1213 Encoding the PER-1 Extended-Spectrum β-Lactamase.

Stefano Mancini1, Laurent Poirel2,3,4, Nicolas Kieffer1,3, Patrice Nordmann1,3,4,5.   

Abstract

PER-1 is an extended-spectrum β-lactamase that is encoded by a gene located in composite transposon Tn1213 made by two distinct insertion sequences, namely, ISPa12 and ISPa13. In vitro mobilization performed in Escherichia coli shows that Tn1213 is functional and is able to mobilize the blaPER-1 gene, although at a very low frequency (ca. 1 × 10-9).
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  PER-1; extended-spectrum beta-lactamase; transposition

Mesh：

Substances：

Year:  2018        PMID： 29311060      PMCID： PMC5826169          DOI： 10.1128/AAC.02453-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods.

Authors:  Laurent Poirel; Rémy A Bonnin; Patrice Nordmann
Journal:  Infect Genet Evol       Date:  2012-03-03       Impact factor: 3.342

2.  PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

3.  Genetic analysis of the interaction of the insertion sequence IS903 transposase with its terminal inverted repeats.

Authors:  K M Derbyshire; L Hwang; N D Grindley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  First report of bla(PER-3) in Acinetobacter baumannii.

Authors:  L Al-Hassan; H El Mahallawy; S G B Amyes
Journal:  Int J Antimicrob Agents       Date:  2012-11-03       Impact factor: 5.283

5.  Molecular Epidemiology and Genetic Characteristics of Various blaPER Genes in Shanghai, China.

Authors:  Lianyan Xie; Jun Wu; Fangfang Zhang; Lizhong Han; Xiaokui Guo; Yuxing Ni; Jingyong Sun
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 6.  Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.

Authors:  Anaïs Potron; Laurent Poirel; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2015-03-24       Impact factor: 5.283

7.  An unusual occurrence of plasmid-mediated blaOXA-23 carbapenemase in clinical isolates of Escherichia coli from India.

Authors:  Deepjyoti Paul; Birson Ingti; Dibyojyoti Bhattacharjee; Anand Prakash Maurya; Debadatta Dhar; Atanu Chakravarty; Amitabha Bhattacharjee
Journal:  Int J Antimicrob Agents       Date:  2017-03-29       Impact factor: 5.283

8.  Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

Authors:  M Quinteros; M Radice; N Gardella; M M Rodriguez; N Costa; D Korbenfeld; E Couto; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina.

Authors:  Roberto Melano; Alejandra Corso; Alejandro Petroni; Daniela Centrón; Betina Orman; Adriana Pereyra; Noemí Moreno; Marcelo Galas
Journal:  J Antimicrob Chemother       Date:  2003-05-29       Impact factor: 5.790

10.  Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  P Nordmann; E Ronco; T Naas; C Duport; Y Michel-Briand; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
View more
  1 in total

1.  Molecular Analyses of Biofilm-Producing Clinical Acinetobacter baumannii Isolates from a South Indian Tertiary Care Hospital.

Authors:  Balaram Khamari; Manmath Lama; Chanakya Pachi Pulusu; Amarendra Pratap Biswal; Sai Manoz Lingamallu; Bhargava Sai Mukkirla; Amit Kumar Sahoo; Harioum Sambhu Narayan Dash; Rewa Sharda; Prakash Kumar; Eswarappa Pradeep Bulagonda
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.